14 results
6-K
CNTB
Connect Biopharma Holdings Ltd
13 Sep 22
Connect Biopharma Reports First Half 2022 Financial Results
4:47pm
million) from insurance recovery. The loss during 2021 primarily resulted from losses arising from a cybersecurity attack experienced in May 2021
F-3/A
CNTB
Connect Biopharma Holdings Ltd
17 Jun 22
Shelf registration (foreign) (amended)
5:19pm
using variable interest entity structure, or VIE structure, adopting new measures to extend the scope of cybersecurity reviews, and expanding … .
Additionally, on December 28, 2021, the Chinese government promulgated amended Cybersecurity Review Measures (the “2022 Cybersecurity Review
F-3/A
CNTB
Connect Biopharma Holdings Ltd
20 May 22
Shelf registration (foreign) (amended)
6:54pm
variable interest entity structure, or VIE structure, adopting new measures to extend the scope of cybersecurity reviews, and expanding the efforts … amended Cybersecurity Review Measures (the “2022 Cybersecurity Review Measures”), which came into effect on February 15, 2022.
According to the 2022
F-3
r04 rdsmf2t7oc8i3zoi
15 Apr 22
Shelf registration (foreign)
5:27pm
20-F
jx7mb3x9mej0kib
31 Mar 22
Annual report (foreign)
4:33pm
424B4
2f4i8a cszhfvqfz
19 Mar 21
Prospectus supplement with pricing info
4:49pm
F-1/A
rgc89dni
18 Mar 21
Registration statement (foreign) (amended)
6:15am
F-1/A
2ze k4m3u0
12 Mar 21
Registration statement (foreign) (amended)
5:02pm
F-1/A
EX-1.1
4s2op6oi8qln fovh9
12 Mar 21
Registration statement (foreign) (amended)
5:02pm
F-1
0o2g5ju
26 Feb 21
Registration statement (foreign)
4:56pm
DRS/A
ax20nxvpzg8zr7em4z
26 Jan 21
Draft registration statement (amended)
12:00am
DRS
12yjl aii9wkhi5s6
17 Dec 20
Draft registration statement
12:00am
- Prev
- 1
- Next